Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 13.4% in March

Ainos, Inc. (NASDAQ:AIMD) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 78,900 shares, a decrease of 13.4% from the March 15th total of 91,100 shares. Based on an average trading volume of 1,840,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 4.8% of the company’s shares are short sold.

Ainos Stock Performance

Shares of AIMD opened at $1.06 on Friday. The firm’s fifty day simple moving average is $1.12 and its two-hundred day simple moving average is $2.06. Ainos has a 12 month low of $0.79 and a 12 month high of $6.10. The stock has a market capitalization of $6.51 million, a P/E ratio of -0.42 and a beta of 1.44. The company has a current ratio of 1.85, a quick ratio of 1.72 and a debt-to-equity ratio of 0.24.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.